{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "12023776",
  "DateCompleted": {
    "Year": "2002",
    "Month": "07",
    "Day": "09"
  },
  "DateRevised": {
    "Year": "2007",
    "Month": "11",
    "Day": "14"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2002",
        "Month": "05",
        "Day": "07"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0022-1899",
      "JournalIssue": {
        "Volume": "185",
        "Issue": "11",
        "PubDate": {
          "Year": "2002",
          "Month": "Jun",
          "Day": "01"
        }
      },
      "Title": "The Journal of infectious diseases",
      "ISOAbbreviation": "J Infect Dis"
    },
    "ArticleTitle": "Relative infectivity of hepatitis A virus by the oral and intravenous routes in 2 species of nonhuman primates.",
    "Pagination": {
      "StartPage": "1668",
      "EndPage": "1671",
      "MedlinePgn": "1668-71"
    },
    "Abstract": {
      "AbstractText": [
        "Hepatitis A virus (HAV) is naturally transmitted by the fecal-oral route but can also be transmitted intravenously. To determine the relative infectivity of these 2 routes, an infectivity titration of a standard challenge pool of virulent HAV was performed in tamarins and chimpanzees. In both species, 1 oral dose of HAV was equivalent to 10(4.5) intravenous doses. These findings have relevance for attempts to develop live, attenuated HAV vaccines that can be administered orally."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Hepatitis Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 50 South Drive, Bethesda, MD 20892-8009, USA. rpurcell@niaid.nih.gov"
          }
        ],
        "LastName": "Purcell",
        "ForeName": "Robert H",
        "Initials": "RH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Wong",
        "ForeName": "Doris C",
        "Initials": "DC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Shapiro",
        "ForeName": "Max",
        "Initials": "M"
      }
    ],
    "GrantList": [
      {
        "GrantID": "N01 AI 52705",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, U.S. Gov't, P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Infect Dis",
    "NlmUniqueID": "0413675",
    "ISSNLinking": "0022-1899"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Models, Animal"
    },
    {
      "QualifierName": [
        "physiopathology",
        "virology"
      ],
      "DescriptorName": "Hepatitis A"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "Hepatitis A virus"
    },
    {
      "QualifierName": [
        "physiopathology",
        "virology"
      ],
      "DescriptorName": "Hepatitis, Viral, Animal"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Injections, Intravenous"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pan troglodytes"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Saguinus"
    }
  ]
}